Development and Validation of a Gene-Based Model for Outcome Prediction in Germ Cell Tumors Using a Combined Genomic and Expression Profiling Approach

• James E. Korkola,

  Current address: Oregon Health & Science University, Portland, Oregon, United States of America

  Affiliation Cell Biology Program, Sloan-Kettering Institute for Cancer Research, New York, New York, United States of America

  ⨯
• Sandy Heck,

  Affiliation Departments of Medicine and Pathology, Weill Cornell Medical College, New York, New York, United States of America

  ⨯
• Adam B. Olshen,

  Current address: University of California San Francisco, San Francisco, California, United States of America

  Affiliation Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Darren R. Feldman,

  Affiliation Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Victor E. Reuter,

  Affiliation Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Jane Houldsworth,

  Current address: Cancer Genetics, Inc., Rutherford, New Jersey, United States of America

  Affiliation Cell Biology Program, Sloan-Kettering Institute for Cancer Research, New York, New York, United States of America

  ⨯
• George J. Bosl,

  Affiliation Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• R. S. K. Chaganti

  * E-mail: chagantr@mskcc.org

  Affiliations Cell Biology Program, Sloan-Kettering Institute for Cancer Research, New York, New York, United States of America, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯